Showing results (2181-2190 of 3,022) with videos related to
Sort By:
Pageof 303
Haematologica|October 30, 2016
Evaluation of the Revised International Staging System in an independent cohort of unselected patients with multiple myelomaEfstathios Kastritis, Evangelos Terpos, Maria Roussou, et al.American Journal of Medical Genetics. Part A|December 1, 2016
Copy number variants in a population-based investigation of Klippel-Trenaunay syndromeAggeliki Dimopoulos, Robert J Sicko, Denise M Kay, et al.Lancet (London, England)|February 19, 2008
Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trialCarlo Di Mario, Dariusz Dudek, Federico Piscione, et al.Cancers|April 3, 2021
Carfilzomib Improves Bone Metabolism in Patients with Advanced Relapsed/Refractory Multiple Myeloma: Results of the CarMMa StudyEvangelos Terpos, Ioannis Ntanasis-Stathopoulos, Eirini Katodritou, et al.Frontiers in Endocrinology|March 11, 2022
Patients With Autoimmune Thyroiditis Present Similar Immunological Response to COVID-19 BNT162b2 mRNA Vaccine With Healthy Subjects, While Vaccination May Affect Thyroid Function: A Clinical StudyStavroula A Paschou, Vangelis Karalis, Theodora Psaltopoulou, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|August 19, 2003
Gut mucosal damage during endotoxic shock is due to mechanisms other than gut ischemiaSuzana M Lobo, Daniel De Backer, Qinghua Sun, et al.American Journal of Clinical Oncology|February 2, 2002
A phase III study of 5-fluorouracil versus 5-fluorouracil plus interferon alpha 2b versus 5-fluorouracil plus leucovorin in patients with advanced colorectal cancer: a Hellenic Cooperative Oncology Group (HeCOG) studyHaralabos P Kalofonos, Costas Nicolaides, Epaminondas Samantas, et al.European Heart Journal|January 29, 2019
Machine learning algorithms estimating prognosis and guiding therapy in adult congenital heart disease: data from a single tertiary centre including 10 019 patientsGerhard-Paul Diller, Aleksander Kempny, Sonya V Babu-Narayan, et al.American Journal of Hematology|January 6, 2015
Effect of cumulative bortezomib dose on survival in multiple myeloma patients receiving bortezomib-melphalan-prednisone in the phase III VISTA studyMaría Victoria Mateos, Paul G Richardson, Meletios A Dimopoulos, et al.Molecular Oncology|November 14, 2017
Dual inhibition of DNMTs and EZH2 can overcome both intrinsic and acquired resistance of myeloma cells to IMiDs in a cereblon-independent mannerKonstantinos Dimopoulos, Alexandra Søgaard Helbo, Helga Fibiger Munch-Petersen, et al.Pageof 303